STEPHEN BUKSH: Open Payments
NPI 1427053396 · EULESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 50 payments from 17 companies in 2025. Trend: 2023 $497 · 2024 $856 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $180 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $93 |
| Amgen Inc. | 5 | $93 |
| Lilly USA, LLC | 4 | $89 |
| Abbott Laboratories | 3 | $74 |
| Novo Nordisk Inc | 4 | $68 |
| ABBVIE INC. | 4 | $66 |
| PFIZER INC. | 3 | $49 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
Products named: TRELEGY ELLIPTA, Kerendia, AIRSUPRA, FREESTYLE LIBRE 3, JARDIANCE, SHINGRIX, VRAYLAR, KRYSTEXXA.
Industry payments across TX — which companies pay providers there.
